The expectation was that the percent of CD4+CD25+CCR7+ cells would be lower in patients than NC, based on our report documenting an enrichment in Treg at tumour sites and tumour-involved lymph nodes relative to the peripheral circulation (Albers et al, 2004). The gene discussed is CD4; the disease is neoplasm.